Want to see IN:ZOTA full AI Analyst Report?
ZOTA Stock Chart & Stats
₹1533.20
₹23.30(2.41%)
At close: 4:00 PM EST
₹1533.20
₹23.30(2.41%)
Day’s Range― - ―
52-Week Range₹1,022.00 - ₹1,740.00
Previous CloseN/A
Volume255.13K
Average Volume (3M)132.90K
Market Cap
₹41.13B
Enterprise Value₹38.65K
Total Cash (Recent Filing)₹955.74M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Nov 18, 2026EPS Estimate
-4.8Next Dividend Ex-DateN/A
Dividend Yield0.07%
Share Statistics
EPS (TTM)-31.35
Shares Outstanding30,332,655
10 Day Avg. Volume180,005
30 Day Avg. Volume132,902
Financial Highlights & Ratios
PEG Ratio-5.04
Price to Book (P/B)5.05
Price to Sales (P/S)6.51
P/FCF Ratio-18.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-13.8
Revenue Forecast (FY)₹9.31B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRapidly accelerating revenue indicates expanding sales of the company’s pharmaceutical portfolio and growing distribution reach. If the business can improve profitability, this larger revenue base could support greater operating scale, stronger market presence, and improved long-term earnings potential.
Branded Generics PortfolioA portfolio spanning multiple therapeutic categories gives Zota several channels for product sales and reduces reliance on a single medicine or treatment area. Branded generics can also support repeat demand and broader healthcare access when paired with effective distribution.
Moderate Reported LeverageThe lower debt-to-equity ratio and larger equity base provide some balance-sheet capacity relative to the company’s liabilities. This can preserve flexibility to fund operations and pursue growth, although the benefit depends on stabilizing losses and converting revenue into cash.
Bears Say
Severe Margin DeteriorationThe sharp gross-margin decline shows that higher sales are not translating into healthy economics, while recurring operating losses indicate the pressure is not merely temporary. Unless pricing, product mix, or costs improve, revenue growth may continue to destroy rather than create value.
Persistent Cash BurnSustained negative operating and free cash flow limits the company’s ability to finance expansion internally and increases dependence on external funding. Continued cash burn also reduces resilience, making execution and a return to cash-positive operations important durable risks.
Rising Debt Amid LossesAlthough reported leverage remains moderate, the rapid increase in debt alongside ongoing losses raises financial risk and can increase funding pressure. Borrowing may support growth in the near term, but weak returns make repayment capacity and future capital allocation less secure.
Zota Health Care Ltd. News
ZOTA FAQ
What was Zota Health Care Ltd.’s price range in the past 12 months?
Zota Health Care Ltd. lowest stock price was ₹1022.00 and its highest was ₹1740.00 in the past 12 months.
What is Zota Health Care Ltd.’s market cap?
Zota Health Care Ltd.’s market cap is ₹41.13B.
When is Zota Health Care Ltd.’s upcoming earnings report date?
Zota Health Care Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 54 days.
How were Zota Health Care Ltd.’s earnings last quarter?
Zota Health Care Ltd. released its earnings results on Aug 13, 2026. The company reported -₹13.2 earnings per share for the quarter.
Is Zota Health Care Ltd. overvalued?
According to Wall Street analysts Zota Health Care Ltd.’s price is currently Overvalued.
Does Zota Health Care Ltd. pay dividends?
Zota Health Care Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.07%. See more information on Zota Health Care Ltd. dividends here
What is Zota Health Care Ltd.’s EPS estimate?
Zota Health Care Ltd.’s EPS estimate is -4.8.
How many shares outstanding does Zota Health Care Ltd. have?
Zota Health Care Ltd. has 30,332,655 shares outstanding.
What happened to Zota Health Care Ltd.’s price movement after its last earnings report?
Zota Health Care Ltd. reported an EPS of -₹13.2 in its last earnings report. Following the earnings report the stock price went down -0.664%.
Which hedge fund is a major shareholder of Zota Health Care Ltd.?
Currently, no hedge funds are holding shares in IN:ZOTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zota Health Care Ltd.
Zota Health Care Limited is an Indian pharmaceutical firm dedicated to the development, manufacturing, and distribution of a broad spectrum of health-related products across India. Its extensive portfolio encompasses generic medications, over-the-counter (OTC) remedies, traditional Ayurvedic formulations, and nutritional supplements (nutraceuticals). The company places a particular emphasis on supplying treatments for various long-term illnesses, including but not limited to heart disease, diabetes, and thyroid conditions. By March 31, 2021, Zota had established a considerable retail network, operating 591 stores under its DAVAINDIA brand name throughout 24 states in India. The company was founded in 1995 and is currently headquartered in Surat, India.
Technical Analysis
Concord Biotech Ltd.
―
Dishman Carbogen Amcis Ltd.
―
Panacea Biotec Limited
―
Supriya Lifescience Limited
―
OneSource Specialty Pharma Limited
―